Effect of apomorphine on cognitive performance and sensorimotor gating in humans

Psychopharmacology

Volumn 207, Issue 4, 2010, Pages 559-569

  Schellekens, Arnt F A ^a,b   Grootens, K P ^a,b   Neef, C ^c   Movig, Kris L L ^d   Buitelaar, J K ^a,b   Ellenbroek, B ^e   Verkes, R J ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MEDISCH SPECTRUM TWENTE   (Netherlands)

^e EVOTEC AG   (Germany)

Author keywords

Apomorphine; Cognition; Dopamine; Neuroendocrine; Prepulse inhibition

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR; GROWTH HORMONE;

ARTICLE; BRAIN LEVEL; CLINICAL TRIAL; COGNITION; COMPARTMENT MODEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FOREBRAIN; FUTUROLOGY; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LIMBIC CORTEX; MALE; NAUSEA; NEUROMODULATION; NEUROPHYSIOLOGY; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; OUTCOME ASSESSMENT; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PROVOCATION TEST; SENSORIMOTOR FUNCTION; SIDE EFFECT; STARTLE REFLEX; TASK PERFORMANCE; YAWNING;

ADMINISTRATION, SUBLINGUAL; ADULT; APOMORPHINE; COGNITION; CROSS-OVER STUDIES; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; GROWTH HORMONE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; PROSENCEPHALON; PSYCHOMOTOR PERFORMANCE; RECEPTORS, DOPAMINE; SENSORY GATING; STARTLE REACTION; YOUNG ADULT;

EID: 72049089036     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1686-1     Document Type: Article

References (62)

1. al-Tikriti MS, Roth RH, Kessler RM, Innis RB (1992) Autoradiographic localization of dopamine D1 and D2 receptors in rat cerebral cortex following unilateral neurotoxic lesions. Brain Res 575:39-46
2. Aymard G, Berlin I, de Brettes B, Diquet B (2003) Pharmacokinetic- pharmacodynamic study of apomorphine's effect on growth hormone secretion in healthy subjects. Fundam Clin Pharmacol 17:473-481 (Pubitemid 36920650)
3. Backman L, Ginovart N, Dixon RA, Wahlin TB, Wahlin A, Halldin C, Farde L (2000) Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am J Psychiatry 157:635-637 (Pubitemid 30191207)
4. Bitsios P, Giakoumaki SG (2005) Relationship of prepulse inhibition of the startle reflex to attentional and executive mechanisms in man. Int J Psychophysiol 55:229-241 (Pubitemid 40093104)
5. Bitsios P, Giakoumaki SG, Frangou S (2005) The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values. Psychopharmacology (Berl) 182:144-152 (Pubitemid 41400871)
6. Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animalmodel studies. Arch Gen Psychiatry 47:181-188
7. Braff DL, Grillon C, Geyer MA (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215
8. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156(2-3):234-58, July
9. Braver TS, Barch DM, Keys BA, Carter CS, Cohen JD, Kaye JA, Janowsky JS, Taylor SF, Yesavage JA, Mumenthaler MS, Jagust WJ, Reed BR (2001) Context processing in older adults: evidence for a theory relating cognitive control to neurobiology in healthy aging. J Exp Psychol Gen 130:746-763
10. Broersen LM, Feldon J, Weiner I (1999) Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion. Neuroscience 94:39-46 (Pubitemid 29457595)
11. Cools R (2008) Role of dopamine in the motivational and cognitive control of behavior. Neuroscientist 14:381-395 (Pubitemid 352010072)
12. Cropley VL, Fujita M, Innis RB, Nathan PJ (2006) Molecular imaging of the dopaminergic system and its association with human cognitive function. Biol Psychiatry 59:898-907
13. Csomor PA, Stadler RR, Feldon J, Yee BK, Geyer MA, Vollenweider FX (2008) Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 33:497-512
14. Duval F, Mokrani MC, Crocq MA, Bailey PE, Diep TS, Correa H, Macher JP (2000) Dopaminergic function and the cortisol response to dexamethasone in psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry 24:207-225 (Pubitemid 30159530)
15. Ellenbroek BA, Budde S, Cools AR (1996) Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience 75:535-542 (Pubitemid 26361342)
16. Essink AW, Lohuis CP, Klein Elhorst JT, Rutten WJ (1991) Selective and quantitative isolation and determination of apomorphine in human plasma. J Chromatogr 570:419-424
17. Fleming K, Bigelow LB, Weinberger DR, Goldberg TE (1995) Neuropsychological effects of amphetamine may correlate with personality characteristics. Psychopharmacol Bull 31:357-362
18. Fletcher PC, Frith CD, Grasby PM, Friston KJ, Dolan RJ (1996) Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia. J Neurosci 16:7055-7062
19. Frank MJ, O'Reilly RC (2006) A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci 120:497-517
20. Friston KJ, Grasby PM, Bench CJ, Frith CD, Cowen PJ, Liddle PF, Frackowiak RS, Dolan R (1992) Measuring the neuromodulatory effects of drugs in man with positron emission tomography. Neurosci Lett 141:106-110
21. Giakoumaki SG, Bitsios P, Frangou S (2006) The level of prepulse inhibition in healthy individuals may index cortical modulation of early information processing. Brain Res 1078:168-170
22. Gibbs SE, D'Esposito M (2005) A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory. Psychopharmacology (Berl) 180:644-653
23. Grasby PM, Friston KJ, Bench CJ, Cowen PJ, Frith CD, Liddle PF, Frackowiak RS, Dolan RJ (1993) The effect of the dopamine agonist, apomorphine on regional cerebral blood flow in normal volunteers. Psychol Med 23:605-612
24. Hamidovic A, Kang UJ, de Wit H (2008) Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. J Clin Psychopharmacol 28:45-51
25. Hofstee DJ, Neef C, van Laar T, Jansen EN (1994) Pharmacokinetics of apomorphine in Parkinson's disease: plasma and cerebrospinal fluid levels in relation to motor responses. Clin Neuropharmacol 17:45-52 (Pubitemid 24046706)
26. Iversen SD, Iversen LL (2007) Dopamine: 50 years in perspective. Trends Neurosci 30:188-193
27. Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, Moore H, Kandel ER (2006) Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49:603-615 (Pubitemid 43221894)
28. Kienast T, Heinz A (2006) Dopamine and the diseased brain. CNS Neurol Disord Drug Targets 5:109-131
29. Kimberg DY, D'Esposito M, Farah MJ (1997) Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 8:3581-3585 (Pubitemid 27497487)
30. Lacroix L, Broersen LM, Feldon J, Weiner I (2000) Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behav Brain Res 107:111-121
31. Langeland W, van den Brink W, Draijer N, Hartgers C (2001) Sensitivity of the Addiction Severity Index physical and sexual assault items: preliminary findings on gender differences. Eur Addict Res 7:193-197 (Pubitemid 34042820)
32. Liechti ME, Geyer MA, Hell D, Vollenweider FX (2001) Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology 24:240-252 (Pubitemid 32144810)
33. Martin-Iverson MT, Else D (2000) PHNO, a selective dopamine D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats. Psychopharmacology (Berl) 151:38-48
34. Mattay VS, Callicott JH, Bertolino A, Heaton I, Frank JA, Coppola R, Berman KF, Goldberg TE, Weinberger DR (2000) Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage 12:268-275 (Pubitemid 30693977)
35. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR (2003) Catechol O- methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100:6186-6191 (Pubitemid 36576952)
36. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M (1992) The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 9:199-213
37. Mehta MA, Swainson R, Ogilvie AD, Sahakian J, Robbins TW (2001) Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. Psychopharmacology (Berl) 159:10-20
38. Meister B, Hokfelt T, Vale WW, Goldstein M (1985) Growth hormone releasing factor (GRF) and dopamine coexist in hypothalamic arcuate neurons. Acta Physiol Scand 124:133-136 (Pubitemid 15038116)
39. Mokrani MC, Duval F, Crocq MA, Bailey PE, Macher JP (1995) Multihormonal responses to apomorphine in mental illness. Psychoneuroendocrinology 20:365-375
40. Neef C, Jelliffe RW, van Laar T, Loohuis T, Essink AW, Janssen EN (1994) Comparison of two software programs to be used for the calculation of population pharmacokinetic parameters. Int J Biomed Comput 36:143-150 (Pubitemid 24173893)
41. Neef C, van Laar T (1999) Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease. Clin Pharmacokinet 37:257-271 (Pubitemid 29452757)
42. Reeves SJ, Grasby PM, Howard RJ, Bantick RA, Asselin MC, Mehta MA (2005) A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition. Neuroimage 28:216-226
43. Sandra Kooij JJ, Marije BA, Swinkels SH, Bekker EM, de Noord I, Buitelaar JK (2008) Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord 11:445-458
44. Schellekens AF, van Oosterwijck AW, Ellenbroek B, de Jong CA, Buitelaar JK, Cools L, Verkes RJ (2009) The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls. Eur Neuropsychopharmacol 19:68-73
45. Schmidt K, Nolte-Zenker B, Patzer J, Bauer M, Schmidt LG, Heinz A (2001) Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence. Pharmacopsychiatry 34:66-72 (Pubitemid 32221751)
46. Seeman P, Van Tol HH (1993) Dopamine receptor pharmacology. Curr Opin Neurol Neurosurg 6:602-608
47. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22-33 (Pubitemid 29001829)
48. Swainson R, Rogers RD, Sahakian BJ, Summers BA, Polkey CE, Robbins TW (2000) Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 38:596-612 (Pubitemid 30109440)
49. Swerdlow NR, Braff DL, Geyer MA (2000) Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 11:185-204
50. Swerdlow NR, Caine SB, Geyer MA (1992) Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl) 108:189-195
51. Swerdlow NR, Geyer MA, Braff DL (2001a) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156:194-215
52. Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Koob GF, Braff DL (1990) Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology (Berl) 100:413-416 (Pubitemid 20052434)
53. Swerdlow NR, Platten A, Shoemaker J, Pitcher L, Auerbach P (2001b) Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl) 158:230-240 (Pubitemid 33071160)
54. Talledo JA, Sutherland Owens AN, Schortinghuis T, Swerdlow NR (2009) Amphetamine effects on startle gating in normal women and female rats. Psychopharmacology (Berl) 204:165-175
55. van der Linden D, Massar SA, Schellekens AF, Ellenbroek BA, Verkes RJ (2006) Disrupted sensorimotor gating due to mental fatigue: preliminary evidence. Int J Psychophysiol 62(1):168-174 (Pubitemid 44307374)
56. van Vliet I, de Beurs E (2007) The MINI-International Neuropsychiatric Interview. A brief structured diagnostic psychiatric interview for DSM-IV en ICD-10 psychiatric disorders. Tijdschr Psychiatr 49:393-397
57. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF (2007) Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 10:376-384 (Pubitemid 46310465)
58. Wan FJ, Geyer MA, Swerdlow NR (1994) Accumbens D2 modulation of sensorimotor gating in rats: assessing anatomical localization. Pharmacol Biochem Behav 49:155-163 (Pubitemid 2136901)
59. Wang H, Pickel VM (2002) Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol 442:392-404 (Pubitemid 34027519)
60. Wilkinson LS (1997) The nature of interactions involving prefrontal and striatal dopamine systems. J Psychopharmacol 11:143-150
61. Zahrt J, Taylor JR, Mathew RG, Arnsten AF (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17:8528-8535 (Pubitemid 27461074)
62. Zavitsanou K, Cranney J, Richardson R (1999) Dopamine antagonists in the orbital prefrontal cortex reduce prepulse inhibition of the acoustic startle reflex in the rat. Pharmacol Biochem Behav 63:55-61 (Pubitemid 29206562)